MeiraGTx Holdings MGTX
NASDAQ MGTX
$9.68 +0.06 (+0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

MeiraGTx Holdings (MGTX) Gains from Sales and Divestitures (2020 - 2026)

Updated

MeiraGTx Holdings (MGTX) reported Gains from Sales and Divestitures of -$45,000 for Q4 2025, compared with $409,000 a year earlier.

Analysis

MeiraGTx Holdings (MGTX) Gains from Sales and Divestitures (2020 - 2026) Analysis & Trends

For FY2025, MeiraGTx Holdings posted Gains from Sales and Divestitures of -$355,000.

  • By year, Gains from Sales and Divestitures came in at -$9,000 in FY2024 and -$56,000 in FY2021.
  • Five-year quarterly Gains from Sales and Divestitures spans a low of -$432,000 in Q3 2025 and a high of $409,000 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 MeiraGTx Holdings 906.09 Mn 610.82 Mn 314.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Mar 31, 2026 -55,000.00
Dec 31, 2025 -45,000.00
Sep 30, 2025 -432,000.00
Mar 31, 2025 122,000.00
Sep 30, 2024 -584,000.00
Mar 31, 2024 29.02 Mn
Dec 31, 2023 54.30 Mn
Dec 31, 2020 -97,000.00
Sep 30, 2020 -10,000.00
Jun 30, 2020 -98,000.00
Mar 31, 2020 -8,000.00
API Access

MeiraGTx Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MGTX&period=max&api_key=YOUR_API_KEY